130 related articles for article (PubMed ID: 30753292)
1. Safety of high-dose intravenous labetalol in hypertensive crisis.
Hecht JP; Mahmood SM; Brandt MM
Am J Health Syst Pharm; 2019 Feb; 76(5):286-292. PubMed ID: 30753292
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
El-Ghoroury H; Sudekum DM; Hecht JP
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
Gaynor MF; Wright GC; Vondracek S
Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
[TBL] [Abstract][Full Text] [Related]
4. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
5. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
6. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
8. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
9. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
10. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
Shekhar S; Sharma C; Thakur S; Verma S
Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
[TBL] [Abstract][Full Text] [Related]
11. Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage.
Jivraj S; Mazer CD; Baker AJ; Choi M; Hare GM
Can J Anaesth; 2006 Jul; 53(7):678-83. PubMed ID: 16803915
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of dexmedetomidine and labetalol for attenuating hemodynamic stress responses during laparoscopic cholecystectomy in borderline hypertensive patients.
Singla D; Parashar A; Pandey V; Mangla M
Rev Esp Anestesiol Reanim (Engl Ed); 2019 Apr; 66(4):181-188. PubMed ID: 30545701
[TBL] [Abstract][Full Text] [Related]
13. The safety of cumulative doses of labetalol in perioperative hypertension.
Cosentino F; Vidt DG; Orlowski JP; Shiesley D; Little JR
Cleve Clin J Med; 1989 Jun; 56(4):371-6. PubMed ID: 2743552
[TBL] [Abstract][Full Text] [Related]
14. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
[TBL] [Abstract][Full Text] [Related]
15. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
[TBL] [Abstract][Full Text] [Related]
17. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
Dux S; Grosskopf I; Boner G; Rosenfeld JB
J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
[TBL] [Abstract][Full Text] [Related]
18. A comparison of nicardipine and labetalol for acute hypertension management following stroke.
Liu-Deryke X; Janisse J; Coplin WM; Parker D; Norris G; Rhoney DH
Neurocrit Care; 2008; 9(2):167-76. PubMed ID: 18250979
[TBL] [Abstract][Full Text] [Related]
19. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
[TBL] [Abstract][Full Text] [Related]
20. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
